CD30: receptor, marker, target
Susan RS Gottesman,1,21Department of Pathology, 2Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY, USA Abstract: CD30 is a member of the tumor necrosis factor receptor family and is expressed on activated lymphocytes and a few other normal cells. Its signaling activates NF-&a...
Main Author: | Gottesman SRS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Pathology and Laboratory Medicine International |
Subjects: | |
Online Access: | https://www.dovepress.com/cd30-receptor-marker-target-peer-reviewed-article-PLMI |
Similar Items
-
THE STANDARD OF CARE IN RELAPSED REFRACTORY CD30+ LYMPHOMA
by: Martin Hutchings
Published: (2014-07-01) -
Challenges of driving CD30-directed CAR-T cells to the clinic
by: Natalie S. Grover, et al.
Published: (2019-03-01) -
The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
by: Adrian Vasile Dumitru, et al.
Published: (2023-07-01) -
The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment
by: Ikhwan Rinaldi
Published: (2018-06-01) -
CD30+ Cutaneous Anaplastic Large-Cell Lymphoma of the Upper Eyelid: A Case Report
by: Stéphanie Olivier, et al.
Published: (2017-10-01)